Holen Sie sich die Stockscreener-App
155.51
1.14%
1.76
Handel nachbörslich:
155.51
Neurocrine Biosciences Inc Aktie (NBIX) Neueste Nachrichten
TD Cowen Issues Positive Forecast for Neurocrine Biosciences (NASDAQ:NBIX) Stock Price - MarketBeat
Earnings Recap: How Neurocrine Biosciences Inc stock performs in weak economyWeekly Trade Report & High Accuracy Trade Alerts - BỘ NỘI VỤ
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Brown Advisory Inc. - MarketBeat
TD Cowen Maintains Neurocrine Biosciences (NBIX) Buy Recommendation - Nasdaq
Saturn V Capital Management LP Makes New Investment in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Will Neurocrine Biosciences Inc. stock split again soonWeekly Loss Report & Free Fast Gain Swing Trade Alerts - Newser
Neurocrine Bio. stock price target raised to $200 from $175 at TD Cowen By Investing.com - Investing.com South Africa
Neurocrine Bio. stock price target raised to $200 from $175 at TD Cowen - Investing.com India
Why Neurocrine Biosciences Inc. (NB3) stock stays on buy listsPortfolio Gains Summary & High Accuracy Trade Signal Alerts - Newser
Dodge & Cox Increases Stake in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
U.S. Tardive Dyskinesia Treatment Market to Reach USD 6417.43 - openPR.com
Will Neurocrine Biosciences Inc. (NB3) stock beat growth indexesOil Prices & Accurate Technical Buy Alerts - Newser
Lyons (Neurocrine Biosciences director) sells $2.29m in NBIX stock - Investing.com
Neurocrine Biosciences Insider Sold Shares Worth $2,289,083, According to a Recent SEC Filing - marketscreener.com
What RSI levels show for Neurocrine Biosciences Inc. (NB3) stockWeekly Trend Summary & Real-Time Buy Zone Alerts - Newser
Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyDollar Strength & Growth Oriented Trade Recommendations - Newser
Will Neurocrine Biosciences Inc. (NB3) stock split increase liquidityDividend Hike & Precise Entry and Exit Recommendations - Newser
Will Neurocrine Biosciences Inc. (NB3) stock benefit from sector leadershipPortfolio Profit Report & Expert Verified Stock Movement Alerts - Newser
Will Neurocrine Biosciences Inc. (NB3) stock gain from green policies2025 Institutional Moves & Weekly High Potential Alerts - Newser
Why Neurocrine Biosciences Inc. (NB3) stock remains top ratedMarket Trend Summary & Daily Technical Forecast Reports - Newser
Fisher Asset Management LLC Trims Stock Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Acadia Stock Up 59% in a Year — Is a $51 Million New Stake a Bet on a Bigger Rebound? - The Motley Fool
Sio Capital Management LLC Lowers Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Mackenzie Financial Corp Has $9.52 Million Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Norges Bank Takes Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Hsbc Holdings PLC - MarketBeat
Korea Investment CORP Cuts Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Russell Investments Group Ltd. Has $10.58 Million Stock Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Can Neurocrine Biosciences Inc. stock attract ESG capital inflowsJuly 2025 Drop Watch & Consistent Growth Stock Picks - Newser
Neurocrine Biosciences fails mid-stage study of depression drug - MSN
Neurocrine Biosciences Insider Sold Shares Worth $905,881, According to a Recent SEC Filing - marketscreener.com
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Virtus Advisers LLC - MarketBeat
Loomis Sayles & Co. L P Acquires New Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences (NBIX) Is Up 5.1% After Peer-Reviewed Study Highlights INGREZZA’s Clinical Profile - simplywall.st
Edgestream Partners L.P. Takes $9.25 Million Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Distillate Capital Partners LLC Sells 8,175 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Can Neurocrine Biosciences Inc. (NB3) stock beat analyst consensusQuarterly Profit Report & Growth Focused Entry Reports - Newser
Deutsche Bank Raises Price Target on Neurocrine Biosciences to $152 From $142, Keeps Hold Rating - marketscreener.com
Skandinaviska Enskilda Banken AB publ Reduces Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Quadrature Capital Ltd Purchases 11,162 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Inceptionr LLC Takes Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Charles Schwab Investment Management Inc. Purchases 13,942 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
(NBIX) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Capital Fund Management S.A. Grows Holdings in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
A Fresh Look at Neurocrine Biosciences (NBIX) Valuation Following New Narrative Review on VMAT2 Therapies - simplywall.st
Neurocrine Bio. stock jumps as rival drug faces modest Medicare price cut - Investing.com Canada
Neurocrine Biosciences, Inc. $NBIX Shares Acquired by CreativeOne Wealth LLC - MarketBeat
Prudential Financial Inc. Purchases 26,030 Shares of Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Neurocrine Biosciences (NBIX): Revisiting Valuation Following Decade-Long VMAT2 Review Publication - Yahoo Finance
Advisors Asset Management Inc. Cuts Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Creative Planning Raises Position in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Published on: 2025-11-28 13:55:28 - BỘ NỘI VỤ
1.91%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):